Inhibrx

Sanofi to buy U.S. drugs project INBRX-101 for about $2.2 billion
Reuters
Tue, 01/23/24 - 10:48 am
Sanofi
M&A
Inhibrx
Inhibrx reports initial Phase I Ewing sarcoma trial data
Clinical Trials Arena
Fri, 11/3/23 - 11:33 am
Inhibrx
INBRX-109
Ewing sarcoma
clinical trials
Two more biotechs leverage upsized offerings in IPO boom as Harbour pitches a raise in Hong Kong
Endpoints
Thu, 08/20/20 - 10:50 am
Harmony Biosciences
Inhibrx
IPOs
Inhibrx takes a second shot at an IPO — this time bumping the goal to $100M-plus
Endpoints
Wed, 07/29/20 - 11:52 pm
Inhibrx
IPOs
Inhibrx Files for $75 Million IPO
CP Wire
Tue, 06/4/19 - 10:57 am
Inhibrx
IPOs
Inhibrx Files for $75 Million IPO
Tue, 06/4/19 - 02:35 pm
Inhibrx
IPOs